ResearcherInstituto Nazionale Tumori Regina ElenaNo recent work listed
Paola Nisticò
Matched on ORCID iD 0000-0003-4409-2261; OpenAlex author ID A5014708462. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 0, last author 1)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 18
2011: 1 paper · 2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: 1 paper · 2017: 1 paper
Papers 5
- Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, and metastasis. Co-author DOI 10.1186/s13045-016-0385-8↗
- The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome. Last author DOI 10.1080/2162402x.2016.1221556↗
- Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. Co-author DOI 10.1186/1756-8722-6-67↗
- Molecular and genetic bases of pancreatic cancer. Co-author DOI 10.2174/138945012800564077↗
- Circulating autoantibodies to phosphorylated α-enolase are a hallmark of pancreatic cancer. Co-author DOI 10.1021/pr100213b↗
Closest collaborators
The 18 strongest of 18 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Paola Cappello · 4 shared papers, 2011–2017 · strength 0.13
- Paper Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, an… DOI 10.1186/s13045-016-0385-8↗
- Paper Molecular and genetic bases of pancreatic cancer. DOI 10.2174/138945012800564077↗
- Paper Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. DOI 10.1186/1756-8722-6-67↗
- Francesco Novelli · 4 shared papers, 2011–2017 · strength 0.13
- Paper Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, an… DOI 10.1186/s13045-016-0385-8↗
- Paper Molecular and genetic bases of pancreatic cancer. DOI 10.2174/138945012800564077↗
- Paper Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. DOI 10.1186/1756-8722-6-67↗
- Michèle Milella · 4 shared papers, 2011–2016 · strength 0.12
- Paper The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome. DOI 10.1080/2162402x.2016.1221556↗
- Paper Molecular and genetic bases of pancreatic cancer. DOI 10.2174/138945012800564077↗
- Paper Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. DOI 10.1186/1756-8722-6-67↗
- Michela Capello · 3 shared papers, 2011–2017 · strength 0.11
- Paper Alpha-enolase (ENO1) controls alpha v/beta 3 integrin expression and regulates pancreatic cancer adhesion, invasion, an… DOI 10.1186/s13045-016-0385-8↗
- Paper Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. DOI 10.1186/1756-8722-6-67↗
- Paper Circulating autoantibodies to phosphorylated α-enolase are a hallmark of pancreatic cancer. DOI 10.1021/pr100213b↗
- Aldo Scarpa Scarpa · 3 shared papers, 2011–2016 · strength 0.10
- Paper The pattern of hMENA isoforms is regulated by TGF-β1 in pancreatic cancer and may predict patient outcome. DOI 10.1080/2162402x.2016.1221556↗
- Paper Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models. DOI 10.1186/1756-8722-6-67↗
- Paper Circulating autoantibodies to phosphorylated α-enolase are a hallmark of pancreatic cancer. DOI 10.1021/pr100213b↗
- Moitza Principe · 1 shared paper, 2017 · strength 0.06
- Simone Borgoni · 1 shared paper, 2017 · strength 0.06
- Matteo Fassan · 1 shared paper, 2016 · strength 0.05
- Roberta Melchionna · 1 shared paper, 2016 · strength 0.05
- Rita Teresa Lawlor · 1 shared paper, 2016 · strength 0.05
- Vanja Vaccaro · 1 shared paper, 2012 · strength 0.03
- Giorgia Mandili · 1 shared paper, 2013 · strength 0.03
- Paolo Vineis · 1 shared paper, 2013 · strength 0.03
- Claudio Bassi · 1 shared paper, 2013 · strength 0.03
- Barbara Tomaino · 1 shared paper, 2011 · strength 0.02
- Paolo Pederzoli · 1 shared paper, 2011 · strength 0.02
- Weidong Zhou · 1 shared paper, 2011 · strength 0.02
- Emanuel F. Petricoin · 1 shared paper, 2011 · strength 0.02
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.